Skip to main navigation Skip to search Skip to main content

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

  • L Tonneijck
  • , MM Smits
  • , MHA Muskiet
  • , T Hoekstra
  • , MHH Kramer
  • , Jan Danser
  • , M Diamant
  • , JA Joles
  • , DH van Raalte

Research output: Contribution to journal › Article › Academic › peer-review

124 Citations (Scopus)
44 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1412-1421
Number of pages10
JournalDiabetologia
Volume59
Issue number7
DOIs
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC COEUR-09
  • EMC COEUR-09-39-02

Cite this